AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Oncologix Tech Inc.

$0 +$0.00 (+0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0$0
Market Cap
73.66K
AVG Volume
40.42K
Trailing/Forward PE
-0.03/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
0500K1M1.5M16 Q116 Q216 Q316 Q417 Q117 Q217 Q317 Q418 Q123 Q1
OCLG Revenue (USD) by quarter
PeriodRevenue (USD)
23 Q10
18 Q1618.53K
17 Q4702.14K
17 Q3842.64K
17 Q2568.55K
17 Q1736.62K
16 Q4897.14K
16 Q3813.19K
16 Q21.13M
16 Q11.17M
Net Income (USD)
-1.5M-1M-500K016 Q116 Q216 Q316 Q417 Q117 Q217 Q317 Q418 Q123 Q1
OCLG Net Income (USD) by quarter
PeriodNet Income (USD)
23 Q1-18.77K
18 Q1-231K
17 Q4-1.29M
17 Q3-190K
17 Q2-593K
17 Q1-292K
16 Q4-1.05M
16 Q3-264K
16 Q2-249K
16 Q1-284K
Operating Income (USD)
-400K-200K0200K16 Q116 Q216 Q316 Q417 Q117 Q217 Q317 Q418 Q123 Q1
OCLG Operating Income (USD) by quarter
PeriodOperating Income (USD)
23 Q1-18.77K
18 Q1-58.53K
17 Q4-361K
17 Q349.11K
17 Q2-394K
17 Q1-159K
16 Q4-357K
16 Q3-95.09K
16 Q2-61.35K
16 Q1832
EBITDA (USD)
-1M-500K0500K16 Q116 Q216 Q316 Q417 Q117 Q217 Q317 Q418 Q123 Q1
OCLG EBITDA (USD) by quarter
PeriodEBITDA (USD)
23 Q1-18.77K
18 Q1-62.09K
17 Q4-617K
17 Q352.94K
17 Q2-391K
17 Q1-156K
16 Q4-974K
16 Q3-109K
16 Q2-57.7K
16 Q16.06K
Cash Flows (USD)
-400K-200K0200K400K13 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q316 Q323 Q1
OCLG Cash Flows (USD) by quarter
PeriodCash Flows (USD)
23 Q1-18.77K
16 Q30
15 Q3-28.97K
15 Q2-167.28K
15 Q1-196.76K
14 Q4-179.28K
14 Q3-83.91K
14 Q2-335.73K
14 Q1-31.9K
13 Q4219.19K
EPS (USD)
-0-0-0-0016 Q116 Q216 Q316 Q417 Q117 Q217 Q317 Q418 Q123 Q1
OCLG EPS (USD) by quarter
PeriodEPS (USD)
23 Q1-0
18 Q1-0
17 Q4-0
17 Q3-0
17 Q2-0
17 Q1-0
16 Q4-0
16 Q3-0
16 Q2-0
16 Q1-0
Expenses (USD)
0200K400K600KR&DSG&ACapex16 Q116 Q216 Q316 Q417 Q117 Q217 Q317 Q418 Q123 Q1
OCLG Expenses (USD) by quarter
PeriodExpenses (USD)
15 Q3867
15 Q2308
15 Q1858
14 Q40
14 Q30
14 Q2462
14 Q1416
13 Q40
23 Q118.77K
18 Q1202.53K
17 Q4463.83K
17 Q3282.87K
17 Q2347.68K
17 Q1342.14K
16 Q4544.07K
16 Q3349.89K
16 Q2407.9K
16 Q1425.38K
Cash & Debt (USD)
01M2M3M4MCashLong Term DebtShort Term Debt14 Q114 Q214 Q314 Q415 Q115 Q215 Q316 Q322 Q423 Q1
OCLG Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
23 Q14.85K
22 Q40
16 Q386.31K
15 Q3120.48K
15 Q228.94K
15 Q177.36K
14 Q417.5K
14 Q3186.38K
14 Q285.25K
14 Q194.14K
Debt ratios
-8-6-4-2013 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q316 Q3
OCLG Debt ratios by quarter
PeriodDebt ratios
16 Q3-5.52
15 Q3-6.45
15 Q2-6.66
15 Q1-4.68
14 Q4-3.26
14 Q3-2.23
14 Q2-2.19
14 Q1-2.57
13 Q4-2.25
13 Q3-2
Margins
-20%0%20%40%15 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q317 Q418 Q1
OCLG Margins by quarter
PeriodMargins
18 Q123.28%
17 Q414.59%
17 Q339.4%
17 Q2-8.18%
17 Q124.9%
16 Q420.87%
16 Q331.84%
16 Q230.7%
16 Q136.37%
15 Q430.62%
Return on Capital
0%50%100%150%13 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q316 Q323 Q1
OCLG Return on Capital by quarter
PeriodReturn on Capital
23 Q1100%
16 Q310.27%
15 Q344.16%
15 Q246.31%
15 Q143.15%
14 Q438.36%
14 Q348.5%
14 Q2131.07%
14 Q150.16%
13 Q4123.63%
Shares Outstanding
0500M1B1.5B2B16 Q116 Q216 Q316 Q417 Q117 Q217 Q317 Q418 Q123 Q1
OCLG Shares Outstanding by quarter
PeriodShares Outstanding
23 Q11.66B
18 Q1772.72M
17 Q4736.62M
17 Q3736.62M
17 Q2736.62M
17 Q1736.62M
16 Q4736.62M
16 Q3738.13M
16 Q2736.62M
16 Q1669.13M
Book Value Per Share (USD)
-0.01-0.01-0-0013 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q316 Q323 Q1
OCLG Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
23 Q1-0
16 Q3-0
15 Q3-0
15 Q2-0.01
15 Q1-0.01
14 Q4-0.01
14 Q3-0
14 Q2-0.01
14 Q1-0
13 Q4-0.01
Total Assets (USD)
01M2M3M4M14 Q114 Q214 Q314 Q415 Q115 Q215 Q316 Q322 Q423 Q1
OCLG Total Assets (USD) by quarter
PeriodTotal Assets (USD)
23 Q14.85K
22 Q40
16 Q33.12M
15 Q33.85M
15 Q23.61M
15 Q13.59M
14 Q42.14M
14 Q32.4M
14 Q22.32M
14 Q12.07M
Free Cash Flow Yield
-1000%-750%-500%-250%0%250%med -61.78%Mar 14Jun 14Oct 14Jan 15May 15Aug 15Nov 15
OCLG Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Nov 15-337.01%
Nov 15-337.01%
Nov 15-337.01%
Nov 15-337.01%
Oct 15-589.77%
Oct 15-589.77%
Oct 15-786.35%
Oct 15-786.35%
Oct 15-471.81%
Sep 15-337.01%
Sep 15-589.77%
Sep 15-393.18%
Sep 15-294.88%
Aug 15-262.12%
Aug 15-294.88%
Aug 15-168.5%
Aug 15-168.5%
Jul 15-138.77%
Jul 15-124.16%
Jul 15-158.13%
Jul 15-151.25%
Jul 15-144.95%
Jun 15-139.15%
Jun 15-139.15%
Jun 15-108.71%
Jun 15-96.63%
May 15-105.42%
May 15-115.96%
May 15-105.42%
May 15-99.39%
May 15-86.97%
Apr 15-86.97%
Apr 15-79.06%
Apr 15-124.18%
Apr 15-119.21%
Mar 15-110.38%
Mar 15-81.65%
Mar 15-88.97%
Mar 15-73.59%
Feb 15-76.42%
Feb 15-54.19%
Feb 15-60.82%
Feb 15-74.51%
Jan 15-77.41%
Jan 15-87.66%
Jan 15-104.57%
Jan 15-144.4%
Jan 15-196.38%
Dec 14-144.4%
Dec 14-129.2%
Dec 14-136.38%
Dec 14-62.73%
Nov 14-47.05%
Nov 14-51.75%
Nov 14-49.29%
Nov 14-47.05%
Oct 14-42.24%
Oct 14-39.06%
Oct 14-41.4%
Oct 14-39.81%
Oct 14-41.4%
Sep 14-37.64%
Sep 14-36.32%
Sep 14-38.33%
Sep 14-36.32%
Aug 14-34.5%
Aug 14-37.64%
Aug 14-35.69%
Aug 14-33.93%
Aug 14-27.97%
Jul 14-28.36%
Jul 14-33.93%
Jul 14-34.92%
Jul 14-42.67%
Jun 14-41.75%
Jun 14-30.48%
Jun 14-30.48%
Jun 14-32.01%
May 14-30.97%
May 14-33.11%
May 14-33.11%
May 14-32.01%
May 14-29.54%
Apr 14-25.95%
Apr 1424.35%
Apr 1428.54%
Apr 1420.76%
Mar 1422.83%
Mar 1423.72%
Mar 1421.49%
Mar 1428.54%
Feb 1419.43%
Feb 1424.68%
Feb 1424.35%
Feb 1418.27%
Jan 1415.22%
Jan 1413.05%
Jan 148.46%
Jan 1410.91%
Jan 1419.39%
Price to Sales
0246med 0.85Mar 21Jun 21Oct 21Jan 22Apr 22Aug 22Nov 22
OCLG Price to Sales by quarter
PeriodPrice to Sales
Nov 220.59
Nov 220.54
Nov 220.59
Nov 220.51
Oct 220.48
Oct 220.45
Oct 220.45
Oct 220.42
Sep 220.45
Sep 220.51
Sep 220.54
Sep 220.59
Sep 220.71
Aug 220.54
Aug 220.57
Aug 220.59
Aug 220.59
Jul 220.62
Jul 220.85
Jul 220.79
Jul 220.99
Jul 221.02
Jun 220.99
Jun 220.88
Jun 220.59
Jun 220.59
May 220.65
May 220.68
May 220.76
May 220.98
Apr 221.56
Apr 222.09
Apr 221.87
Apr 222.01
Apr 221.23
Mar 221.24
Mar 220.96
Mar 220.85
Mar 220.99
Feb 220.76
Feb 220.85
Feb 220.93
Feb 220.93
Jan 221.58
Jan 221.73
Jan 222.55
Jan 222.55
Dec 212.57
Dec 212.32
Dec 212.52
Dec 212.32
Dec 211.95
Nov 212.32
Nov 212.09
Nov 213.08
Nov 213.31
Oct 213.85
Oct 215.37
Oct 214.41
Oct 214.5
Oct 214.81
Sep 214.5
Sep 213.31
Sep 212.63
Sep 212.74
Aug 212.43
Aug 212.94
Aug 213.34
Aug 213.11
Jul 213.96
Jul 213.39
Jul 212.12
Jul 211.78
Jul 211.44
Jun 211.16
Jun 210.85
Jun 211.1
Jun 211.05
May 210.74
May 210.45
May 210.42
May 210.42
Apr 210.28
Apr 210.25
Apr 210.17
Apr 210.2
Apr 210.2
Mar 210.2
Mar 210.2
Mar 210.2
Mar 210.23
Feb 210.31
Feb 210.48
Feb 210.4
Feb 210.23
Jan 210.17
Jan 210.14
Jan 210.11
Jan 210.11
Dec 200.14
Price/Operating Cashflow
2.557.51012.5med 4.97Jan 14Jan 14Feb 14Mar 14Mar 14Apr 14
OCLG Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Apr 144.09
Apr 143.49
Apr 144.8
Mar 144.37
Mar 144.2
Mar 144.64
Mar 143.49
Feb 145.13
Feb 144.04
Feb 144.09
Feb 145.46
Jan 146.55
Jan 147.64
Jan 1411.79
Jan 149.16
Jan 145.16
Dec 137.32
Dec 137.32
Oncologix Tech Inc.
OCLG
Stockpicker

Video analysis: OCLG

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.